Covered recipient · General Payments record
KENNETH A MARTIN
Allopathic & Osteopathic Physicians Orthopaedic Surgery
General Payments · PY2018–2024
$404,367.36
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Royalty or License | $11,613.49 | 4 |
| Consulting Fee | $2,100.00 | 1 |
| Food and Beverage | $144.61 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Arthrex, Inc. | $11,613.49 | 4 |
| MEDACTA USA, INC. | $2,100.00 | 1 |
| Pacira Pharmaceuticals Incorporated | $51.55 | 1 |
| Heron Therapeutics, Inc. | $43.73 | 1 |
| Vericel Corporation | $30.35 | 2 |
| Innovation Technologies Inc | $18.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Arthrex, Inc. | $4,762.73 | 02/15/2024 | Royalty or License | Undisputed | 01/23/2026 | 1146527446 | CMS |
| Arthrex, Inc. | $3,788.86 | 05/15/2024 | Royalty or License | Undisputed | 01/23/2026 | 1146527442 | CMS |
| Arthrex, Inc. | $2,309.07 | 08/15/2024 | Royalty or License | Undisputed | 01/23/2026 | 1146527438 | CMS |
| Arthrex, Inc. | $752.83 | 11/15/2024 | Royalty or License | Undisputed | 01/23/2026 | 1146527435 | CMS |
| Heron Therapeutics, Inc. | $43.73 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147247740 | CMS |
| Innovation Technologies Inc | $18.98 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130822310 | CMS |
| MEDACTA USA, INC. | $2,100.00 | 05/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143686488 | CMS |
| Pacira Pharmaceuticals Incorporated | $51.55 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151251329 | CMS |
| Vericel Corporation | $16.13 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128574882 | CMS |
| Vericel Corporation | $14.22 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128574884 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.